CVS Health Announces It Will Drop Zepbound and Prioritize Coverage of Wegovy
New OTC Option Offers Patients Itch Relief During Summer Activities
Zepbound Shows Superior Weight Loss Compared to Wegovy in SURMOUNT-5 Trial
Anitocabtagene Autoleucel Yields Overall Response Rate of 97% in Patients With Multiple Myeloma